Article Details

ABVC BioPharma Shares Rise 19% After Studies for Vitargus - MarketWatch

Retrieved on: 2021-08-26 14:48:45

Tags for this article:

Click the tags to see associated articles and topics

ABVC BioPharma Shares Rise 19% After Studies for Vitargus - MarketWatch. View article details on hiswai:

Excerpt

The biopharmaceutical company's Vitargus is a bio-degradable vitreous substitute intended to facilitate retina re-attachment surgery. ABVC has selected the ...

Article found on: www.marketwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up